Programme

09:00 – 12:00
Pre-Congress Course: Clinical & Laboratory Perspectives on HIT and APS
A comprehensive review of current diagnostic strategies, laboratory methodologies, and their implications for clinical management
Course leaders: Julieta Bomfim & Per Öst

11:00 – 12:00
Nordic Hemophilia Council’s Annual General Meeting
Official notice will be issued separately.

11:00 – 13:30
Registration and Exhibition Opens – Light lunch available

12:30 – 13:15
Industry-sponsored mini-sessions

• Novo Nordisk / Novel Treatment Strategies and Perioperative Management in Haemophilia B

• Takeda / Von Willebrand Disease throughout life

13:30 – 13:45
Welcome and Opening Remarks
Speaker: Maria Bruzelius

13:45 – 15:00
Liver Disorder – Haemostasis and Thrombosis
Chairs: Maria Magnusson & Hans Hemmingsson
Speakers:

• 13:50-14:15 Guidelines on Portal Vein Thrombosis / Virginia Hernandez-Gea, Spain

• 14:15-14:30 Novel haemostatic assays and biomarkers in patients with liver cirrhosis, the HELICS project / Sanna Norén, Karolinska Institutet

• 14:30-14:50: Multidisciplinary patient case on Kasabach-Merritt Syndrome / Hans Hemmingsson, Marie Sund and Tatiana von Bahr Greenwood, Karolinska Institutet

• 14:50-15:00 Q&A

15:00 – 15:30
Coffee Break – Exhibition Area

15:30 – 16:45
Platelet Disorders and treatment
Chairs: Charlotte Gran & David Schmidt
Speakers:

• 15:35-16:05 An update on Glanzmann Thrombasthenia / Roger Schutgens, Utrecht, The Netherlands

• 16:05-16:20 Platelet function testing by flow cytometry in clinical settings – possibilities and challenges / Sofia Ramström, Örebro University, Sweden

• 16:20-16:35 Improving diagnostic work-up of platelet function disorders / David Schmidt, Local Faculty

• 16:35-16:45 Q&A

16:45 – 19:00
Reception – Exhibition Area
Featuring live gypsy jazz by Belleville Trio

17:00-17:45
Guided Poster Walk
Chairs: Margareta Holmström, Andries Blokzijl & David Schmidt
Five selected posters for presentation:

1. Assessment of von Willebrand Disease Using the Total Thrombus-Formation Analysis System (T-TAS)
   LJ Mettis / University of Helsinki, Finland & North Estonia Medical Centre, Tallinn, Estonia
2. Thrombin-antithrombin and thrombin generation across pregnancy and postpartum in healthy women with and without heterozygous FV Leiden mutation
   Marit Hellum, University of Oslo & Oslo University Hospital, Oslo, Norway
3. Thrombolysis and infraclavicular first rib resection for primary subclavian venous thrombosis – results from a population-based strategy
   Jonas Malmstedt / Karolinska Institutet & Södersjukhuset, Stockholm, Sweden
4. Pharmacomechanical Thrombolysis for Acute Deep Vein Thrombosis: Patient Profiles and Anticoagulant Outcomes at Helsinki University Hospital
   Matti Kaksonen / University of Helsinki & Helsinki University Hospital /Helsinki, Finland
5. Bleeding in acute leukemia and lymphoid malignancies with arterial thrombosis – a retrospective single-center study at Karolinska University Hospital
   Ivan Bekhali, Karolinska Institutet, Stockholm / Karolinska University Hospital, Stockholm, Sweden

08:00 – 09:00
Poster viewing and exhibition visit

08:00 – 08:45
Industry-sponsored mini-sessions

• Pfizer / From Trial to Treatment Centre: Marstacimab OLE Updates and Practical Insights from the Clinic

09:00 – 10:15
Haemophilia and bleeding disorders in clinical practice
Chairs: Susanna Ranta & Petra Elfvinge
Speakers:

• 9:05-9:35 Experience with novel treatment options in haemophilia in Germany / Christoph Königs, Frankfurt, Germany

• 9:35-9:50 FVIII-Mimetic Treatment in Acquired Haemophilia A: Insights from the Karolinska Experience / Maria Bruzelius, Local Faculty

• 9:50-10:05 Building psychological resilience in patients with chronic disease / Karl Björk, Karolinska University Hospital

• 10:05-10:15: Q&A

10:15 – 10:45
Coffee Break – Exhibition Area

10:45 – 12:00

Haemophilia – Laboratory Insights
Chairs: Maria Farm & Niklas Bark
Speakers:

• 10:45-10:55 Evolution of the Chromogenic Assays / Niklas Bark, Local Faculty

• 10:55-11:25 Assessing Haemostatic Function in Emerging Non-Factor Therapies for Hemophilia / Peter Lenting, Paris, France

• 11:25-11:35 Estimating the Haemostatic Capacity in Patients with Emicizumab / Adrian Kimiaei, Local Faculty

• 11:35-11:50 Clinical Outcomes of Emicizumab Monitoring at Karolinska / Tony Frisk, Local Faculty

• 11:50-12:00 Q&A

12:00 – 13:15
Lunch Break – Exhibition Area

12:20 – 13:05
Industry-sponsored mini-sessions

• Roche / When the Future Becomes the Norm – The Recent Evolution of the Therapeutic Landscape for Hemophilia A
• Sobi / From Bleed Prevention to Life Long Joint Health – Will Normalized Haemostasis in Haemophilia A take us there?

13:15 – 14:30
Thrombosis Over Time: Risk Factors, Acute Events and Residual Disease
Chairs: Joel Ohm & Tony Frisk
Speakers:

• 13:20-13:50 A new era with bioidentical oestrogens – balancing benefits and thrombotic risk / Kristina Gemzell Danielsson, Karolinska Institutet

• 13:50-14:05 Pulmonary embolism as a cause of cardiac arrest and death: age and sex differences / Emma Bendz, Karolinska Institutet

• 14:05-14:20 Magnetic Resonance Direct Thrombus Imaging / Gargi Gautam, Karolinska Institutet

• 14:20-14:30 Q&A

14:30 – 15:00
Coffee Break – Exhibition Area

15:00 – 16:15
Complexity in Thrombosis: Life-Course Determinants and Clinical Practice
Chairs: Natali Karandyszowska & Emma Skau
Speakers:

• 15:05-15:25 Family history, socioeconomy and cardiovascular disease / Per Svensson, Karolinska Institutet

• 15:25-15:45 Prosthetic heart valve thrombosis / Mika Skeppholm, Karolinska Institutet

• 15:45-16:05 Primary subclavian vein thrombosis – results of treatment with early catheter-directed thrombolysis followed by decompression of the thoracic outlet / Jonas Malmstedt, Karolinska Institutet

• 16:05-16:15 Q&A

16:15 – 16:30
Break – Exhibition Area

16:30 – 17:30
War, crises and haemostatic challenges
Chairs: Marjan Shafaati Lambert & Torsten Dahlén
Speakers:

• 16:30-16:45 Pre-hospital blood for civilian trauma in conflicts / Johan von Schreeb, Karolinska Institutet

• 16:45-17:00 Blood preparedness in emergencies / Agneta Wikman, Karolinska Institutet

• 17:00-17:15 Challenges in blood transfusion when resources are limited / Märit Halmin, Karolinska Institutet

• 17:15-17:30 Q&A

19:00 –
Congress Dinner at Urban Deli Hagastaden

08:00 – 09:00
Poster viewing and exhibition visit

08:00 – 08:45
Industry-sponsored mini-sessions

• Bayer / DO NOT TAKE IT PERSONALLY. Be personalized

09:00 – 10:15

Cancer Associated Thrombosis – from mechanism to treatment
Chairs: Roza Chaireti & Axel Rosell

Speakers:

• 09:05-09:35 The role of haemostatic and inflammatory biomarkers in solid cancers / Anna Falanga, Milano, Italy

• 09:35-09:45 Venous thromboembolism as the first sign of malignancy / Axel Rosell, Local Faculty

• 09.45-09:55 Thromboembolism in ALLTogether1: A NOPHO Study / Lovisa Malmqvist, Karolinska Institutet

• 09:55-10:05 Neutrophil extracellular trap formation in myeloproliferative neoplasms / Ingrid Lundahl, Karolinska Institutet

• 10:05-10:15 Q&A

10:15 – 10:45
Coffee Break – Exhibition Area

10:45 – 12:00

Von Willebrand Disease
Chairs: Anna Ågren & Adrian Kimiaei

Speakers:

• 10:50-11:20 von Willebrand Disease: Linking Pathophysiology, Diagnostics, and Patient Management / Omid Seidizadeh, Milano, Italy 

• 11:20-11:35 Insights from Approximately 300 von Willebrand Disease Genetic Investigations / August Lundholm, Local Faculty

• 11:35-11:50 Acquired von Willebrand Disease / Anna Ågren, Local Faculty

• 11:50-12:00 Q&A

12:00 – 12:30

Poster Award and Closing Remarks

Speaker: Maria Bruzelius